基于数据挖掘探讨许华教授干预造血干细胞移植后患儿经验

doi:10.20274/j.cnki.issn.1674-3865.2026.02.013

Abstract

Abstract:

Objective To explore the patterns of traditional Chinese medicine (TCM) usage in Professor Xu Hua's interventions for pediatric patients post-hematopoietic stem cell transplantation (HSCT) through data mining techniques， summarize her clinical experience， and provide references for promoting the clinical application of TCM in the field of pediatric HSCT. Methods Prescriptions from pediatric patients treated by Professor Xu Hua at the First Affiliated Hospital of Guangzhou University of Chinese Medicine (outpatient or inpatient) between January 1， 2021， and December 12， 2024， were collected. Various data mining techniques， including frequency， dosage， and property analysis of TCM， association rule analysis， complex network construction， core TCM clustering analysis， and community analysis of compatible TCM， were employed to objectively present Professor Xu Hua's medication patterns. Results A total of 230 prescriptions involving 177 TCM herbs were included. The four natures of the herbs were predominantly warm， neutral， and slightly warm， while the five flavors were mainly sweet， pungent， and bitter. The meridians most frequently targeted were the spleen， lung， and stomach. The top five herb pairs with the highest co-occurrence frequency were Pinellia ternata(Fabanxia)-Poria(Fuling)， stir-fried Atractylodes macrocephala(Fuchaobaizhu)-Poria(Fuling)， stir-fried Atractylodes macrocephala(Fuchaobaizhu)-Pinellia ternata(Fabanxia)， tangerine peel(Chenpi)-stir-fried Atractylodes macrocephala(Fuchaobaizhu)， and tangerine peel(Chenpi)-Poria(Fuling). Herb pairs with 100% confidence included honey-fried Ephedra(Mimahuang)-bitter apricot kernel(Kuxingren)， Peucedanum praeruptorum(Qianhu)-bitter apricot kernel(Kuxingren)， dragon bone(Longgu)-oyster shell(Muli)， Ilex pubescens(Maudongqing)-honey-fried Ephedra(Mimahuang)， Ilex pubescens(Maudongqing)-bitter apricot kernel(Kuxingren)， and clam shell(Haqiao)-Pinellia ternata(Fabanxia). Six categories of core TCM prescriptions were identified， with Category 1(comprising Pseudostellaria heterophylla(Taizishen)， Poria(Fuling)， stir-fried Atractylodes macrocephala(Fuchaobaizhu)， Aucklandia lappa(Muxiang)， Pueraria lobata(Gegen)， Pogostemon cablin(Guanghuoxiang)， Pinellia ternata(Fabanxia)， tangerine peel(Chenpi)， charred hawthorn(Jiaoshanzha)， and licorice slice(Gancaopian) containing the most frequently used herbs. Conclusion Professor Xu Hua's interventions for pediatric patients post-HSCT primarily focus on strengthening the spleen's function， complemented by replenishing qi and nourishing yin， regulating the lung and kidney， resolving phlegm， and dispelling stasis. She prefers using herbs that serve both medicinal and dietary purposes， aiding in the generation and circulation of qi， blood， and body fluids in post-HSCT children， thereby improving the dysfunction or deficiency of multiple organs.

Key words: Hematopoietic stem cell transplantation, Traditional Chinese medicine, Famous physician experience, Medication patterns, Data mining, Child

CLC Number:

R272

Baoyi HUANG, Lichen YI, Yabin CHEN, Hua XU. Exploring Professor Xu Hua's experience in treating pediatric patients post-hematopoietic stem cell trans⁃plantation based on data mining[J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(2): 157-167.

Figures/Tables 14

Table 1

Fig.1

Fig.2

Fig.3

Table 2

Table3

Fig.4

Table 4

Fig.5

Table 5

Fig.6

Table 6

Fig.7

Table 7

References 31

[1]	Sugiyanto M， Gosal S， Kosim A， et al. Impact of the source of hematopoietic stem cells on immune reconstitution after transplantation： a systematic review[J]. Eur J Haematol， 2023， 111(1)： 4-14.
[2]	DeFilipp Z， Alousi AM， Pidala JA， et al. Nonrelapse mortality among patients diagnosed with chronic GVHD： an updated analysis from the Chronic GVHD Consortium[J]. Blood Adv， 2021， 5(20)： 4278-4284.
[3]	Diep PP， Rueegg CS， Burman MM， et al. Graft-versus-host-disease and health-related quality of life in young long-term survivors of cancer and allogeneic hematopoietic stem cell transplantation[J]. J Adolesc Young Adult Oncol， 2023， 12(1)： 66-75.
[4]	Fleischer T， Chang TT， Yen HR. Post-hematopoietic stem cell transplantation in patients with hematologic disorders： Chinese herbal medicine for an unmet need[J]. J Integr Med， 2016， 14(5)： 322-335.
[5]	国家药典委员会. 中华人民共和国药典-一部： 2020年版[M]. 北京：中国医药科技出版社， 2020.
[6]	南京中医药大学. 中药大辞典[M]. 2版. 上海：上海科学技术出版社， 2014.
[7]	国家中医药管理局. 中华本草[M]. 上海：上海科学技术出版社， 1999.
[8]	《全国中草药汇编》编写组. 全国中草药汇编[M]. 北京：人民卫生出版社， 1975.
[9]	但文超，赵国桢，何庆勇，等.中医药处方数据挖掘的常见问题辨析与展望[J].中国中药杂志，2023，48(17)：4812-4818.
[10]	Seidman SB. Network structure and minimum degree[J]. Soc Netw， 1983， 5(3)： 269-287.
[11]	何佳怡，谢佳东，胡晨骏，等. 基于图神经网络的中药聚类方法研究[J]. 世界科学技术-中医药现代化， 2024，26(11)： 2988-2995.
[12]	Blondel V， Guillaume JL， Lambiotte R. Fast unfolding of communities in large networks： 15 years later[J]. J Stat Mech， 2024(10)： 10R001.
[13]	Girvan M， Newman MJ. Community structure in social and biological networks[J]. Proc Natl Acad Sci USA， 2002， 99(12)： 7821-7826.
[14]	任晓龙，吕琳媛.网络重要节点排序方法综述[J].科学通报，2014，59(13)：1175-1197.
[15]	金·李杲. 脾胃论[M]. 北京：中国中医药出版社， 2019.
[16]	江育仁.脾健不在补贵在运：运脾法在儿科临床的实践意义[J].中医杂志，1983(1)：4-6.
[17]	黄宝仪，易立琛，李平甘，等.100例造血干细胞移植后患儿中医证候分布特点的潜在类别及隐结构分析[J].中医杂志，2025，66(17)：1783-1792.
[18]	宋·钱乙. 小儿药证直诀[M]. 北京：中国医药科学技术出版社， 2021.
[19]	闵思明，赵晓瑶，陈赛红，等. 太子参参须多糖对免疫抑制小鼠的免疫调节作用研究[J]. 动物医学进展， 2020， 41(8)： 23-28.
[20]	赵佳梅，杜蓥蓥，曾丽，等.太子参多糖对OVA免疫小鼠肠道免疫应答能力的影响[J].福建农林大学学报(自然科学版)，2024，53(6)：772-778.
[21]	谢骏，王媛媛，李聚鑫，等.茯苓多糖调控Rho-ROCK信号通路对心肌缺血再灌注损伤大鼠心肌细胞凋亡的影响和机制研究[J].中国中药杂志，2023，48(23)：6434-6441.
[22]	董永杰，董静，贾辉，等.茯苓酸调节VEGFC/VEGFR3信号通路抑制结直肠癌免疫逃逸[J].中国老年学杂志，2024，44(23)：5840-5845.
[23]	Zhao H， Liu T， Yang CE， et al. Poricoic acid A attenuates renal fibrosis by inhibiting endoplasmic reticulum stress-mediated apoptosis[J]. Braz J Med Biol Res， 2024， 57： e14249.
[24]	张森，豆晓霞，刘晓东，等. 白术多糖对动物免疫调节作用研究进展[J]. 饲料工业， 2024， 45(19)： 20-25.
[25]	Chen C， Sun Y， Wang Z， et al. Pinellia genus： a systematic review of active ingredients， pharmacological effects and action mechanism， toxicological evaluation， and multi-omics application[J]. Gene， 2023， 870： 147426.
[26]	清·沈金鳌. 杂病源流犀烛[M]. 李占永，李晓林校注. 北京：中国中医药出版社， 1994.
[27]	谢铱子，张欣欣，黄慧婷，等.特发性肺纤维化特征基因和靶向中药的探索与验证[J].中草药，2024，55(21)：7381-7398.
[28]	黄帝内经·素问[M]. 周鸿飞，范涛点校.郑州：河南科学技术出版社， 2017.
[29]	黄帝内经·灵枢[M]. 太原：山西科学技术出版社， 2019.
[30]	清·孙星衍，孙冯翼. 神农本草经[M]. 太原：山西科学技术出版社， 2018.
[31]	明·李时珍. 本草纲目[M]. 张守康主校. 北京：中国中医药出版社， 1998.

药物	频次	频率（%）	最小剂量（g）	平均剂量（g）	最大剂量（g）	药物	频次	频率（%）	最小剂量（g）	平均剂量（g）	最大剂量（g）
甘草片	168	73.04	4	6.05	12	苦杏仁	62	26.96	8	9.84	10
茯苓	155	67.39	10	15.26	50	炙甘草	61	26.52	5	9.13	10
麸炒白术	154	66.96	8	10.51	15	人参片	60	26.09	6	12.85	20
法半夏	147	63.91	6	8.96	10	酒萸肉	58	25.22	10	12.84	15
焦山楂	132	57.39	10	12.92	30	炒酸枣仁	51	22.17	10	17.16	20
陈皮	128	55.65	3	7.30	10	山药	49	21.30	15	18.88	30
太子参	102	44.35	10	15.69	30	五指毛桃	48	20.87	15	23.85	30
木香	91	39.57	4	6.53	10	姜厚朴	46	20.00	8	12.30	15
葛根	88	38.26	10	16.07	30	茯神	42	18.26	10	17.86	20
广藿香	87	37.83	5	8.56	10	款冬花	42	18.26	5	5.64	10
牡蛎	75	32.61	15	29.80	30	蜜麻黄	42	18.26	8	11.00	15
砂仁	72	31.30	3	6.47	10	麸炒枳实	37	16.09	8	11.19	15
苍术	67	29.13	8	11.01	15	甘草泡地龙	37	16.09	10	14.05	15
防风	63	27.39	10	19.44	30	前胡	34	14.78	8	9.71	10
黄芪	63	27.39	5	9.76	10	五味子	34	14.78	5	6.18	10

中药A	中药B	支持度（%）	A→B置信度（%）	B→A置信度（%）	提升度（%）	中药A	中药B	支持度（%）	A→B置信度（%）	B→A置信度（%）	提升度（%）
法半夏	茯苓	46.96	73.47	69.68	1.09	太子参	茯苓	30.00	67.65	44.52	1.00
麸炒白术	茯苓	45.22	67.53	67.10	1.00	太子参	麸炒白术	30.00	67.65	44.81	1.01
麸炒白术	法半夏	43.04	64.29	67.35	1.01	木香	麸炒白术	29.57	74.73	44.16	1.12
陈皮	麸炒白术	41.74	75.00	62.34	1.12	广藿香	焦山楂	29.13	77.01	50.76	1.34
陈皮	茯苓	41.30	74.22	61.29	1.10	葛根	焦山楂	28.70	75.00	50.00	1.31
焦山楂	茯苓	40.43	70.45	60.00	1.05	木香	茯苓	28.70	72.53	42.58	1.08
焦山楂	麸炒白术	40.00	69.70	59.74	1.04	焦山楂	木香	28.26	49.24	71.43	1.24
陈皮	焦山楂	38.26	68.75	66.67	1.20	木香	法半夏	27.83	70.33	43.54	1.10
陈皮	法半夏	38.26	68.75	59.86	1.08	葛根	茯苓	26.52	69.32	39.35	1.03
广藿香	葛根	37.39	98.85	97.73	2.58	广藿香	法半夏	26.09	68.97	40.82	1.08
葛根	木香	35.65	93.18	90.11	2.36	广藿香	茯苓	26.09	68.97	38.71	1.02
木香	广藿香	35.65	90.11	94.25	2.38	葛根	法半夏	26.09	68.18	40.82	1.07
太子参	焦山楂	31.74	71.57	55.30	1.25	太子参	陈皮	26.09	58.82	46.88	1.06
葛根	麸炒白术	30.87	80.68	46.10	1.20	太子参	木香	24.78	55.88	62.64	1.41
麸炒白术	广藿香	30.43	45.45	80.46	1.20	葛根	太子参	24.35	63.64	54.90	1.43

中药A	中药B	A→B置信度（%）	B→A置信度（%）	支持度（%）	提升度（%）	中药A	中药B	A→B置信度（%）	B→A置信度（%）	支持度（%）	提升度（%）
蜜麻黄	苦杏仁	100.00	67.74	18.26	3.71	甘草泡地龙	法半夏	91.89	23.13	14.78	1.44
前胡	苦杏仁	100.00	54.84	14.78	3.71	鸡内金	麸炒白术	91.30	13.64	9.13	1.36
龙骨	牡蛎	100.00	37.33	12.17	3.07	款冬花	苦杏仁	90.48	61.29	16.52	3.36
毛冬青	蜜麻黄	100.00	64.29	11.74	5.48	黄芩片	法半夏	89.66	17.69	11.30	1.40
毛冬青	苦杏仁	100.00	43.55	11.74	3.71	毛冬青	茯苓	88.89	15.48	10.43	1.32
蛤壳	法半夏	100.00	16.33	10.43	1.56	蜜麻黄	法半夏	88.10	25.17	16.09	1.38
广藿香	葛根	98.85	97.73	37.39	2.58	西洋参	牡蛎	86.96	26.67	8.70	2.67
毛冬青	法半夏	96.30	17.69	11.30	1.51	鸡内金	焦山楂	86.96	15.15	8.70	1.52
蛤壳	蜜麻黄	95.83	54.76	10.00	5.25	茯神	麸炒白术	85.71	23.38	15.65	1.28
蛤壳	苦杏仁	95.83	37.10	10.00	3.56	通草	法半夏	84.62	14.97	9.57	1.32
款冬花	法半夏	95.24	27.21	17.39	1.49	干石斛	牡蛎	84.00	28.00	9.13	2.58
广藿香	木香	94.25	90.11	35.65	2.38	苦杏仁	法半夏	83.87	35.37	22.61	1.31
前胡	蜜麻黄	94.12	76.19	13.91	5.15	麸炒枳实	麸炒白术	83.78	20.13	13.48	1.25
五味子	茯苓	94.12	20.65	13.91	1.40	甘草泡地龙	苦杏仁	83.78	50.00	13.48	3.11
葛根	木香	93.18	90.11	35.65	2.36	佛手	法半夏	83.33	13.61	8.70	1.30

参数	数值
节点个数	177
边个数	4 345
平均路径长度	1.724
平均节点度	49.096
网络直径	3
平均聚类系数	0.874

中药	度中心性	接近中心性	介数中心性	中药	度中心性	接近中心性	介数中心性
甘草片	0.88	0.89	933.96	苦杏仁	0.60	0.72	263.14
茯苓	0.85	0.87	740.97	炙甘草	0.64	0.73	285.72
麸炒白术	0.81	0.84	600.12	人参片	0.67	0.75	376.63
法半夏	0.82	0.85	712.04	酒萸肉	0.57	0.70	165.75
焦山楂	0.77	0.81	476.75	炒酸枣仁	0.59	0.71	158.42
陈皮	0.78	0.82	493.75	山药	0.44	0.64	75.14
太子参	0.69	0.76	277.93	五指毛桃	0.59	0.71	176.71
木香	0.65	0.74	218.20	姜厚朴	0.61	0.72	244.69
葛根	0.66	0.75	271.35	茯神	0.59	0.71	186.79
广藿香	0.63	0.73	205.34	蜜麻黄	0.42	0.63	80.34
牡蛎	0.64	0.73	233.56	款冬花	0.41	0.63	51.33
砂仁	0.66	0.75	294.80	麸炒枳实	0.46	0.65	92.09
苍术	0.68	0.76	306.32	甘草泡地龙	0.37	0.61	29.78
防风	0.61	0.72	211.48	五味子	0.40	0.62	58.67
黄芪	0.57	0.70	148.60	前胡	0.38	0.62	51.77

Exploring Professor Xu Hua's experience in treating pediatric patients post-hematopoietic stem cell trans⁃plantation based on data mining

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 14

References 31

Related Articles 15

Recommended Articles

Metrics

Comments

类别	中药组成
类别1	太子参、茯苓、麸炒白术、木香、葛根、广藿香、法半夏、陈皮、焦山楂、甘草片
类别2	牡蛎、砂仁、苍术、防风、黄芪、炙甘草、人参片、酒萸肉、炒酸枣仁、山药、五指毛桃、姜厚朴、茯神、建曲、龙骨、鸡内金、西洋参、白术
类别3	蜜麻黄、苦杏仁、前胡、款冬花、甘草泡地龙、毛冬青、蛤壳
类别4	麸炒枳实、地黄、乌梅、当归、土茯苓、蝉蜕
类别5	五味子、党参片、黄芩片、连翘、通草、北柴胡、佛手、麸炒枳壳、桂枝、鸡血藤、丹参、仙鹤草、熟地黄、浙贝母、薏苡仁、紫菀、紫苏梗
类别6	干鱼腥草、辛夷、炒苍耳子、白芷

社团	中药组成
社团1	干石斛、玄参、灯心草、酒女贞子、墨旱莲、麦冬、牡丹皮、炒麦芽、白芍、白茅根、炒稻芽、白薇、菝葜、麻黄、桑螵蛸、金樱子肉、糯稻根、牛膝、玉米须、浮小麦、醋龟甲、半枝莲、山慈菇、益智仁
社团2	淫羊藿、川芎、柏子仁、小茴香、化橘红、淡附片、赤芍、肉桂、火麻仁、百部、细辛、全蝎、桑白皮、白屈菜、盐菟丝子、酒苁蓉、射干、鹅管石、百合、青黛、炒僵蚕、地骨皮、重楼、干姜
社团3	泽泻、茵陈、莲子、猪苓、白花蛇舌草、芡实、车前子、醋延胡索、乌梅炭、广金钱草、诃子、黄连片、海金沙、山楂炭、龙胆、栀子、虎杖、佩兰、布渣叶、两面针、蚕砂、青皮、丁香
社团4	紫草、知母、徐长卿、芦根、地肤子、紫苏叶、荆芥穗、桔梗、苦参、岗梅、淡豆豉、白鲜皮、大青叶、青蒿、生石膏、鹅不食草
社团5	夏枯草、豆蔻、淡竹叶、净山楂、猫爪草、皂角刺、槟榔、滑石、当归尾、金银花、醋没药、醋乳香、枸杞子、决明子、青葙子、白扁豆、广东神曲

[1]	Siyuan HU, Qinglong GU, Xuefeng WANG, Fengying QIAO, Rong MA, Daxin LIU, Qiuhan CAI, Yan CHEN. Expert consensus on the diagnosis, treatment and efficacy evaluation of pediatric acute rhinosinusitis in integrated traditional Chinese and Western medicine [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 369-375.
[2]	Jiaxuan WANG, Jinghua DU. Experience in the application of pediatric Tuina to the treatment of functional constipation in children from the perspective of spleen deficiency based on the "brain-gut axis" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 376-380.
[3]	Yilin CHEN, Yating ZHANG, Hui LI. Treating pediatric functional constipation of Qi-Yin deficiency syndrome based on the theory of "tonifying to relieve obstruction" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 381-385.
[4]	Hongjie HAO, Xiaozheng DUAN, Aoning LIU. Experience in treating pediatric constipation of food accumulation and lung-heat syndrome based on the theory of "Sanjiao Qi transformation" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 386-390.
[5]	Hui LIU, Xiaojuan XU, Mingming GENG. Research progress on early diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 391-398.
[6]	Xinrui ZHANG, Mingxin E, Xuefeng WANG, Xiuying ZHANG, Jingwen MU. First-round Delphi expert consultation on traditional Chinese medicine syndromes of functional dyspepsia in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 399-407.
[7]	Bo LI, Jiaoyan LIAO, Zijing LIAO, Tingting ZHU, Feng ZHANG. Analysis of rehabilitation efficacy of sling exercise training combined with press needle therapy in spastic diplegic cerebral palsy [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 413-418.
[8]	Yaowei HAN, Huizhe WANG, Huanmin LI, Liting MA, Dan SUN, Hongxiang CHEN, Shuo YANG, Kunya FU, Mingze LIU, Xinmin LI. Clinical observation of the "Qingxuan Tongluo" method in the treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 419-424.
[9]	Huafang LIANG, Na GAN, Lining WANG, Jianshu WEI, Yi LIANG. Analysis of medication rules and clinical experience of Professor Wang Lining in treating pediatric recurrent respiratory tract infections during the acute infection phase [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 425-429.
[10]	Jiahui LIU, Hanjing WANG, Yuting ZHANG, Xue LAN, Weiwei LIU. Medication characteristics of traditional Chinese medicine in the treatment of Helicobacter pylori infection-related recurrent abdominal pain in children: a data mining analysis [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 430-435.
[11]	Chen WANG, Lizhong DING. Stage-based syndrome-differentiated treatment for pediatric asthma based on the theory of "latent phlegm-blood stasis" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 436-439.
[12]	Dake XUAN, Yuanxian LIU, Baoshan QIU. Exploring the impact of oral and nasal breathing patterns on pediatric obstructive sleep apnea based on the theory of pectoral Qi [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 440-444.
[13]	Hongxu QU, Bin XIE. Exploration in the pathogenic evolution and syndrome treatment strategies of allergic diseases in children by Professor Wang Xuefeng based on the theory of "host-guest interaction" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 445-450.
[14]	Xin ZHOU, Zhenqi WU. Study on the application of insect medicines in pediatric tic disorder based on "collateral disease theory" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 451-455.
[15]	Yiru JIANG, Fang LIU. Treatment for pediatric bronchopneumonia based on the theory of "subduing what governs the disease" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 456-460.